Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 2013

View Archived Issues

KaloBios Pharmaceuticals prepares novel monoclonal antibodies for COPD

FDA grants second fast track designation for MABp1

Data from genome-wide association study in patients with anemia published

Computational integration of schizophrenia-related genomics uncovers functional gene networks

Novel candidate antidiabetic drugs patented by Ajinomoto

Roche presents new TaR-1 ligands

Novel HIV vaccine adjuvants created by French investigators

Arena Pharmaceuticals prepares new GPR119 receptor ligands

Researchers study novel PRMT5 inhibitors for the treatment of beta-thalassemia and SCD

FDA grants QIDP designation to Paratek Pharmaceuticals' omadacycline

FDA clears IND for TGR-1202 studies

Kyowa Hakko Kirin advances second oncology candidate under agreement with Dicerna

Immunovaccine reports preclinical data on DepoVax-based anthrax vaccines

Investigators develop mouse model for evaluation of anti-human CD37 therapeutics

Philogen enters into worldwide licensing agreement with Pfizer for Dekavil

Savant obtains NIDA funding for preclinical development of 18-MC

Development of a low-cost, large-scale, multiplex-targeted, candidate gene mutation screen

FDA clears IND to investigate OrbeShield in GI-ARS

Receptos commences patient dosing in phase II trial of RPC-1063 in ulcerative colitis

Phase II trial of RM-493 for treatment of obesity begins

Data suggest 12-mg Proellex-V dose optimal for uterine fibroid treatment

Proteon Therapeutics reports results from study of recombinant human elastase

Bayer files application in Japan for use of VEGF TrapEye in macular edema following CRVO

iCo Therapeutics provides update on phase II iCo-007 trial

Biogen Idec files BLA for long-lasting factor IX therapy for hemophilia B

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...